Accuray Incorporated (ARAY) 1.96 -0.06 (-2.97%)
1.96 -0.06 (-2.97%)
US0043971052 - Common Stock - After market: 1.96 0 (0%)
Accuray Incorporated1.96
NASDAQ:ARAY (6/30/2022, 7:00:01 PM)-0.06 (-2.97%)
| GICS Sector | Health Care | ||
| GICS Industry | Health Care Equipment & Supplies | ||
| Valuation | Growth | ||
| Profitability | Health | ||
| Dividend | |||
| Earnings (Last) | 04-27 2022-04-27/amc | Earnings (Next) | 08-09 2022-08-09 |
| Ins Owners | 4.42% | Inst Owners | 74.97% |
| Market Cap | 181.89M | Shares | 92.80M |
| PE | N/A | Fwd PE | 56.52 |
| Dividend Yield | N/A | Analysts | 85.45 |
| IPO | 02-08 2007-02-08 | ||
Stock Screener Links
Nasdaq Stock Screener
Find more stocks on Nasdaq
USA Stock Screener
Find more stocks on the USA
GICS Sector Stock Screener
Find competitors from the same sector on the USA
GICS Industry Stock Screener
Find competitors from the same industry on the USA
Technical Stock Screener
Find stocks with similar TA and Setup ratings on the USA
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Technical Competitors Stock Screener
Find the competitors with the best technical ratings on the USA
Best Technical Setups Competitors Stock Screener
Find the competitors with the best technical and setup ratings on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA
Company Profile
Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
Company Info
Accuray Incorporated
1310 Chesapeake Ter
Sunnyvale CALIFORNIA 94089
P: 14087164600.0
CEO: Joshua H. Levine
Employees: 995
Website: http://www.accuray.com/
News
16 days ago - Accuray IncorporatedAccuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Franco N. Palomba has joined the company as vice president, chief accounting officer &...
25 days ago - Accuray IncorporatedAccuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Sandeep Chalke, the...
a month ago - Accuray IncorporatedAccuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and Limbus AI Inc. announced today they are partnering to augment Accuray adaptive radiotherapy...
2 months ago - Accuray IncorporatedAccuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Sandeep Chalke has joined the company as senior vice president, chief commercial...
2 months ago - Accuray IncorporatedNew Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range of Indications and Complexities/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that clinical studies continue to validate the versatility of the company's CyberKnife® and...
ARAY Twits
Here you can normally see the latest stock twits on ARAY, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
